Respiratory News and Research

RSS

InterCure signs strategic service agreement with private company

XTL Biopharmaceuticals Ltd. today announced that InterCure Ltd., which is approximately 45.4% (50.79% on a fully diluted basis) held by XTL, signed a strategic service agreement with a private company wholly owned by Mr. Shay Ben Yitzhak and Mr. Avner Yassur.

25 Sep 2012

Sudanese refugee camps see improvement in water, food provisions, but concerns remain over disease threats, overcrowding

"Aid agencies say water and food provision has improved in four camps housing more than 105,000 refugees from Sudan's Blue Nile State, but flooding, disease and an influx of additional refugees pose new threats," IRIN reports, noting, "Sudan's government forces and rebels have been fighting in Blue Nile State since September 2011, sending refugees south."

25 Sep 2012

Confusion reigns on best handover of patients from secondary to primary care

Several planned interventions have reportedly improved the quality and safety of patient handovers between hospital and primary care, yet robust evidence of their benefits is still lacking, conclude researchers who conducted a systematic review of studies to date.

24 Sep 2012

Study on epigenetics link of PTSD and respiratory disease in 9/11 responders

The "Epigenetics Link of PTSD and Respiratory Disease in 9/11 Responders" study is the first to investigate the association between genetic changes and the development of both conditions in the 9/11 responder patient population. Approximately 500 patients treated at the LI-CCE for both conditions will be evaluated during the two-year study.

24 Sep 2012

FDA clears Teleflex’s ARROW FlexBlock continuous peripheral nerve block catheter

Teleflex Incorporated today announced the ARROW FlexBlock continuous peripheral nerve block catheter has received 510(k) clearance from the U.S. Food and Drug Administration (FDA).

24 Sep 2012

Boehringer Ingelheim completes enrollment in nintedanib Phase III trials for IPF

Boehringer Ingelheim is pleased to announce the last patients have been randomised into the Phase III sister trials assessing the efficacy and safety of nintedanib (150 mg twice daily) in patients with idiopathic pulmonary fibrosis (IPF).

24 Sep 2012

Adult stem cell therapy may benefit COPD patients

New developments in regenerative medicine are bringing about exciting, novel approaches to create therapies for hard to treat diseases. Chronic obstructive pulmonary disease (COPD) is a hard to treat disorder that progressively blocks airflow in the lungs making it increasingly difficult for an individual to breathe, and is one of the leading illnesses in the US. Yet, current treatments for COPD can only try to limit the extent of damage to the lungs, and to bring some relief from symptoms.

21 Sep 2012

Secondhand smoke continues to take a grievous toll on nonsmokers

Secondhand smoke is accountable for 42,000 deaths annually to nonsmokers in the United States, including nearly 900 infants, according to a new UCSF study.

21 Sep 2012

Routine tests flag up cancer danger in cryptogenic stroke

Blood tests and imaging findings could point to hidden malignancies in patients with cryptogenic stroke, say researchers.

21 Sep 2012

Arthroplasty wound complications linked to oral anticoagulant use

Multicenter research suggests that recovery from hip or knee arthroplasty may be significantly affected by choice of pharmaceutical thromboprophylaxis.

21 Sep 2012

Changing iv catheters only when necessary 'could benefit millions'

Peripheral intravenous catheters need be removed only when clinically indicated, rather than every 72 to 96 hours, as is currently recommended, conclude Australian researchers in findings that could have dramatic patient and cost benefits.

21 Sep 2012

Same-day discharge after laparoscopic hysterectomy ‘poses no safety concerns’

Researchers say that patients undergoing laparoscopic hysterectomy can be discharged the same day, with no associated safety concerns.

21 Sep 2012

Patients with chronic obstructive pulmonary disease experience poor sleep quality

Patients with chronic obstructive pulmonary disease (COPD) experience poorer sleep quality than people of a similar age without COPD, according to research published in the journal Respirology.

21 Sep 2012

FDA approves Acton’s AEROSPAN sNDA to treat asthma

Acton Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved the sNDA (Supplemental New Drug Application) for AEROSPAN (flunisolide HFA, 80 mcg) Inhalation Aerosol, a hydrofluoroalkane (HFA) orally inhaled corticosteroid indicated for the maintenance treatment of asthma as a prophylactic therapy in adult and pediatric patients 6 years of age and older.

21 Sep 2012

Positive results from Galleon GAL-021 second Phase I study on respiratory depression

Galleon Pharmaceuticals, a leader in the development of novel medicines to treat breathing control disorders, today announced that results from a second Phase I clinical study of its investigational drug GAL-021 confirmed previous findings that the drug has dose-dependent effects on respiration.

21 Sep 2012

Tight glycemic control does not reduce infection rate after pediatric cardiac surgery

Implementing tight glycemic control after surgery with cardiopulmonary bypass does not reduce the rate of healthcare-associated infections among pediatric patients, compared with standard care in the intensive care unit, show US study results.

20 Sep 2012

Study analyzes effectiveness of ultrasonography in diagnosis and treatment of critical care patients

A study published in the October issue of Anesthesiology analyzed the effectiveness of ultrasound examination in the diagnosis and treatment of critical care patients. In particular, the study looked at the ability of ultrasound to detect hidden anomalies, prompt urgent changes in therapy, induce further testing or interventions, and confirm or modify diagnoses.

20 Sep 2012